Development of the next generation of HIV-1 integrase inhibitors: pyrazolone as a novel inhibitor scaffold.

Abstract excerpt

HIV-1 integrase (IN), one of the essential enzymes in HIV infection, has been validated as a target for HIV treatment. While more than 20 drugs have been approved by the FDA to treat HIV/AIDS, only one drug, Raltegravir (1), was approved as an IN inhibitor. The rapid mutation of the virus, which leads to multidrug resistant HIV strains, presents an urgent need to find potent compounds that can serve as...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Catalysis
• Share to HIV-1
• Share to HIV Integrase Inhibitors